{"id":5263,"date":"2017-08-30T07:20:56","date_gmt":"2017-08-30T05:20:56","guid":{"rendered":"https:\/\/staging.capitalmind.com\/deals\/sale-of-bertin-pharmas-pharmaceutical-development-activities-to-amatsigroup\/"},"modified":"2020-01-22T17:54:21","modified_gmt":"2020-01-22T16:54:21","slug":"verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten","status":"publish","type":"deals","link":"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/","title":{"rendered":"Verkoop van Bertin Pharma\u2019s farmaceutische ontwikkelingsactiviteiten"},"content":{"rendered":"<h2>Wat we voor Bertin Pharma hebben gedaan<\/h2>\n<p>Investec ondersteunde de CNIM Group tijdens het gehele verkoop proces: voorbereiding van de marketingdocumentatie, onderzoek naar en selectie van strategische kopers en het begeleiden bij carve-out problemen.<\/p>\n<h2>Over de verkoop van Bertin Pharma aan Amatsi Group<\/h2>\n<p>Amatsi Group heeft de farmaceutische ontwikkelingsactiviteiten van Bertin Pharma overgenomen.<br \/>\nAmatsi Group, een dochteronderneming van de Eurofins Group, is een farmaceutisch ontwikkelingsbedrijf met een portfolio van meer dan 300 internationale klanten met spelers van zowel de farmaceutische als de biotech industrie. In 2016 genereerde het bedrijf een omzet van 45 miljoen euro en had het meer dan 350 zeer capabele werknemers binnen life sciences.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wat we voor Bertin Pharma hebben gedaan Investec ondersteunde de CNIM Group tijdens het gehele verkoop proces: voorbereiding van de&#8230;<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[3746,3761,3745,3747],"sector":[3765],"dealtype":[3704,3723],"clienttype":[3696],"class_list":["post-5263","deals","type-deals","status-publish","hentry","dt-betrokken-beursgenoteerde-bedrijven-nl","dt-betrokken-investeerder-nl","dt-carve-out-nl","dt-familiebedrijf-nl","sector-gezondheidszorg-nl","dealtype-bedrijf-verkopen-nl","dealtype-carve-out-nl","clienttype-familiebedrijven-nl"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.10 (Yoast SEO v26.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Verkoop van Bertin Pharma\u2019s farmaceutische ontwikkelingsactiviteiten | Investec Business Advisory<\/title>\n<meta name=\"description\" content=\"Investec adviseerde CNIM Group bij de verkoop van de farmaceutische ontwikkelingsactiviteiten van Bertin Pharma aan Amatsigroup (Eurofins)\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verkoop van Bertin Pharma\u2019s farmaceutische ontwikkelingsactiviteiten\" \/>\n<meta property=\"og:description\" content=\"Investec adviseerde CNIM Group bij de verkoop van de farmaceutische ontwikkelingsactiviteiten van Bertin Pharma aan Amatsigroup (Eurofins)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/\" \/>\n<meta property=\"og:site_name\" content=\"Investec Business Advisory\" \/>\n<meta property=\"article:modified_time\" content=\"2020-01-22T16:54:21+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/\",\"url\":\"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/\",\"name\":\"Verkoop van Bertin Pharma\u2019s farmaceutische ontwikkelingsactiviteiten | Investec Business Advisory\",\"isPartOf\":{\"@id\":\"https:\/\/working.capitalmind.com\/nl\/#website\"},\"datePublished\":\"2017-08-30T05:20:56+00:00\",\"dateModified\":\"2020-01-22T16:54:21+00:00\",\"description\":\"Investec adviseerde CNIM Group bij de verkoop van de farmaceutische ontwikkelingsactiviteiten van Bertin Pharma aan Amatsigroup (Eurofins)\",\"breadcrumb\":{\"@id\":\"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/working.capitalmind.com\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Verkoop van Bertin Pharma\u2019s farmaceutische ontwikkelingsactiviteiten\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/working.capitalmind.com\/nl\/#website\",\"url\":\"https:\/\/working.capitalmind.com\/nl\/\",\"name\":\"Investec Business Advisory\",\"description\":\"Investec Business Advisory\",\"publisher\":{\"@id\":\"https:\/\/working.capitalmind.com\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/working.capitalmind.com\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/working.capitalmind.com\/nl\/#organization\",\"name\":\"Capitalmind Investec\",\"url\":\"https:\/\/working.capitalmind.com\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/working.capitalmind.com\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg\",\"contentUrl\":\"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg\",\"width\":1120,\"height\":1121,\"caption\":\"Capitalmind Investec\"},\"image\":{\"@id\":\"https:\/\/working.capitalmind.com\/nl\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory\",\"https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Verkoop van Bertin Pharma\u2019s farmaceutische ontwikkelingsactiviteiten | Investec Business Advisory","description":"Investec adviseerde CNIM Group bij de verkoop van de farmaceutische ontwikkelingsactiviteiten van Bertin Pharma aan Amatsigroup (Eurofins)","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"nl_NL","og_type":"article","og_title":"Verkoop van Bertin Pharma\u2019s farmaceutische ontwikkelingsactiviteiten","og_description":"Investec adviseerde CNIM Group bij de verkoop van de farmaceutische ontwikkelingsactiviteiten van Bertin Pharma aan Amatsigroup (Eurofins)","og_url":"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/","og_site_name":"Investec Business Advisory","article_modified_time":"2020-01-22T16:54:21+00:00","twitter_card":"summary_large_image","twitter_misc":{"Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/","url":"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/","name":"Verkoop van Bertin Pharma\u2019s farmaceutische ontwikkelingsactiviteiten | Investec Business Advisory","isPartOf":{"@id":"https:\/\/working.capitalmind.com\/nl\/#website"},"datePublished":"2017-08-30T05:20:56+00:00","dateModified":"2020-01-22T16:54:21+00:00","description":"Investec adviseerde CNIM Group bij de verkoop van de farmaceutische ontwikkelingsactiviteiten van Bertin Pharma aan Amatsigroup (Eurofins)","breadcrumb":{"@id":"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/working.capitalmind.com\/nl\/deals\/verkoop-van-bertin-pharmas-farmaceutische-ontwikkelingsactiviteiten\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/working.capitalmind.com\/nl\/"},{"@type":"ListItem","position":2,"name":"Verkoop van Bertin Pharma\u2019s farmaceutische ontwikkelingsactiviteiten"}]},{"@type":"WebSite","@id":"https:\/\/working.capitalmind.com\/nl\/#website","url":"https:\/\/working.capitalmind.com\/nl\/","name":"Investec Business Advisory","description":"Investec Business Advisory","publisher":{"@id":"https:\/\/working.capitalmind.com\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/working.capitalmind.com\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/working.capitalmind.com\/nl\/#organization","name":"Capitalmind Investec","url":"https:\/\/working.capitalmind.com\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/working.capitalmind.com\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","contentUrl":"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","width":1120,"height":1121,"caption":"Capitalmind Investec"},"image":{"@id":"https:\/\/working.capitalmind.com\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory","https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w"]}]}},"_links":{"self":[{"href":"https:\/\/working.capitalmind.com\/nl\/wp-json\/wp\/v2\/deals\/5263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/working.capitalmind.com\/nl\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/working.capitalmind.com\/nl\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/working.capitalmind.com\/nl\/wp-json\/wp\/v2\/media?parent=5263"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/working.capitalmind.com\/nl\/wp-json\/wp\/v2\/dt?post=5263"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/working.capitalmind.com\/nl\/wp-json\/wp\/v2\/sector?post=5263"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/working.capitalmind.com\/nl\/wp-json\/wp\/v2\/dealtype?post=5263"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/working.capitalmind.com\/nl\/wp-json\/wp\/v2\/clienttype?post=5263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}